# CORRESP — BioCardia, Inc.  (BCDA)  (CIK 0000925741)

> <strong>BioCardia, Inc.  (BCDA)  (CIK 0000925741) → SEC staff</strong> · filed 2025-09-17 · ticker BCDA · SIC 2836

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001437749-25-029247
- **Form:** CORRESP
- **Filer:** BioCardia, Inc.  (BCDA)  (CIK 0000925741)
- **CIK:** 0000925741
- **Ticker:** BCDA
- **Filed:** 2025-09-17
- **SIC industry:** 2836
- **HQ:** Sunnyvale, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/925741/000143774925029247/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=925741&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for BioCardia, Inc.  (BCDA)  (CIK 0000925741)

- CORRESP — 2025-09-16 — /comment-letter/0001437749-25-029146

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, BioCardia, Inc.  (BCDA)  (CIK 0000925741) (CIK 0000925741), filed 2025-09-17, accession 0001437749-25-029247. Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/comment-letter/0001437749-25-029247.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*
